Contacts | Pfizer Benefits   
 
  • Stay Informed
  • Get Involved
  • Be Healthy
  • Know Your Benefits
  • Visit Community Corner
    •

Focus On... The Common Cold

Sneezing, runny nose, coughing, body aches and scratchy throat — yuk! These unpleasant symptoms are tell-tale signs that you have a cold coming on.

Read more

Join the 2018 Pfizer Annual Giving Campaign

The 2018 Pfizer Annual Giving Campaign is currently under way and will continue through November 30, 2018.

Read more

Retiree Spotlight:
Jack Mitchell

Jack Mitchell is living the sweet life in retirement. Literally.


Read more

Vaccinations: Not Just For Kids

Find out why vaccinations are important for adults and how up-to-date immunizations can protect you from deadly diseases.

Read more

Understanding Medicaid:
The Basics

When limited income and assets factor into your health, Medicaid can often be a lifeline.


Read more

Challenge These Four Myths About Aging

In our youth-worshipping culture, gloomy stereotypes about getting older persist.


Read more

This Playwright Wrote His First Play at 80, and Became a Part of the Growing Senior Theatre Community

When Arthur Keyser was 80, he wrote his first play.

Read more

Be the Next Retiree Spotlight

Interested in being featured as a retiree spotlight? We would love to hear from you. Email us today to be featured in the next Pfizer Retiree Spotlight!


Contact Us

Items of Interest

Have a Question About
Your Benefits?

Visit the Pfizer Benefits Center for answers!

Visit the Community Corner

Read Retiree Spotlights, learn about upcoming events and more!

Pfizer Zero Cost Drug List

An updated Pfizer Zero Copay Drug List / Greenstone Generic Drug List is now available. (October 2017)

Preventive Care:
What You Should Know

Preventive care services include lab tests, screenings, exams, and vaccines. These services can help find health problems early when they often are most treatable, or can keep you from getting certain diseases or illnesses.

Pfizer News


  • U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC
    Mon, 12 Nov 2018
  • PFIZER REPORTS THIRD-QUARTER 2018 RESULTS
    Tue, 13 Nov 2018
  • Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH
    Mon, 12 Nov 2018
  • Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients
    Tue, 30 Oct 2018
  • BAIN CAPITAL AND PFIZER CREATE CEREVEL THERAPEUTICS, NEW CNS COMPANY
    Tue, 23 Oct 2018
  • Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer
    Sat, 03 Nov 2018
  • U.S. FDA Approves TALZENNA® (talazoparib)
    Fri, 26 Oct 2018
  • Pfizer Announces Executive Leadership Team
    Tue, 16 Oct 2018

There's no one way to

Fear Less. Live Longer.

Get Inspired & Learn More

Join the Pfizer Plus Community Corner

When you join the PfizerPlus.com community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • PfizerPlus.com Community

Sign Up Now

Member Sign-In
Copyright © 2018 Pfizer Inc All Rights Reserved | Contact Us | Terms of Use | Privacy Statement